{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0013046/OMIM:612932","label":"Glycogen storage disease XIII","mondoId":"MONDO:0013046","onsetQualifier":null,"recordKeys":["5861d724ba03b1f8348799af15fe7dd41b3e4f420470a9d340831785f6f05742","5fae574ed7ba9cefd5b2a22a85c598665d8293aa097ec4ea7a654d524dc9d0b4","663d11584d16d400517e4120fffdbb089aca059e41cbc7a57cee18c910847661","75adbe0e9d26e5a781809ba3cf68df1e516b7988d4b37f8e7d5e4f3e95487d78","e09decd91cdb06e43245aac1f5d444a2de808f16367aaaf9fd6c45fe43f6af6d"],"recordQualifiers":{},"scopeLabel":"OMIM:612932","sourceIds":["OMIM:612932"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0013046/OMIM:612932"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":1,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":5,"sourceGroups":{"omim":4,"orphanet":0,"published":1}},"features":[{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":false},{"hpoId":"HP:0003546","label":"Exercise intolerance","primary":false},{"hpoId":"HP:0009051","label":"Increased muscle glycogen content","primary":false},{"hpoId":"HP:0003326","label":"Myalgia","primary":false},{"hpoId":"HP:0034633","label":"Reduced muscle enolase activity","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0013046","records":[{"frequencyKind":"reported","key":"5861d724ba03b1f8348799af15fe7dd41b3e4f420470a9d340831785f6f05742","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:612932","disease_name":"Glycogen storage disease XIII","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0009051","is_excluded":false,"label":"Increased muscle glycogen content","onset_id":null,"reference":"OMIM:612932","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"5fae574ed7ba9cefd5b2a22a85c598665d8293aa097ec4ea7a654d524dc9d0b4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:612932","disease_name":"Glycogen storage disease XIII","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"OMIM:612932","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"663d11584d16d400517e4120fffdbb089aca059e41cbc7a57cee18c910847661","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:612932","disease_name":"Glycogen storage disease XIII","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003326","is_excluded":false,"label":"Myalgia","onset_id":null,"reference":"OMIM:612932","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"75adbe0e9d26e5a781809ba3cf68df1e516b7988d4b37f8e7d5e4f3e95487d78","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:612932","disease_name":"Glycogen storage disease XIII","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003546","is_excluded":false,"label":"Exercise intolerance","onset_id":null,"reference":"OMIM:612932","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"e09decd91cdb06e43245aac1f5d444a2de808f16367aaaf9fd6c45fe43f6af6d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:612932","disease_name":"Glycogen storage disease XIII","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0034633","is_excluded":false,"label":"Reduced muscle enolase activity","onset_id":null,"reference":"PMID:11506403","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"glycogen-storage-disease-due-to-muscle-beta-enolase-deficiency","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"glycogen storage disease due to muscle beta-enolase deficiency"},"schemaVersion":1}